| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0007 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0007 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0007 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0008 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.001 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |